UNSPSC 51272408: Sevoflurane

This classification denotes an anesthetic agent with the molecular formula C4H3F7O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38LVP0K73A, chemically known as 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane but generally known as sevoflurane, which bears US NIH Compound Identifier 5206. European Medicines Agency schedules Sevoflurane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10506MIG.

UNSPSC 51272408 Sevoflurane is a Commodity code, but the recent state and local opportunities tagged under it do not reflect sevoflurane procurement — instead, they document purchases of naloxone, safe drug deactivation systems, and multi-source generic pharmaceuticals and OTC products. The code shows a fundamental mismatch between its nominal scope (a specific anesthetic agent) and the actual work being solicited. State and local governments do acquire anesthetics and pharmaceuticals through formal procurement, but this code's recent activity does not surface relevant sevoflurane-specific opportunities.

The three recent opportunities posted between January and July 2026 come from different issuing bodies pursuing disparate pharmaceutical and medical-supply categories: Seminole County, Florida (naloxone and drug deactivation systems via IFB); the Texas Health and Human Services Commission (direct-to-manufacturer pharmacy benefit exploration via RFI); and the Minnesota Multistate Cooperative Purchasing Alliance (generic multi-source pharmaceuticals and OTC products via RFP with response due March 26, 2026). None target sevoflurane directly. The code exhibits little relevant recent activity for sevoflurane sourcing and warrants further investigation into whether the tagging reflects a data classification error or whether state and local procurement of sevoflurane operates under a different code or through existing pharmaceutical master agreements that do not generate visible solicitation activity.